TMates Review: $158 Is a Year Paid Up Front. One Month Is $249.

$249 a month for compounded semaglutide and $297 for compounded tirzepatide, if you buy one month. The $158 and $167 on the shop page are the twelve-month plans divided by twelve: $1,900 and $1,999, charged as a block. TMates's own page data makes the distinction explicit — the plan record stores `price: 1900` and `perMonth: 158`, so the block is the transaction and the monthly figure is a label on it. The one-month price is corroborated by the structured data TMates emits for search engines, which reports `"offers":{"price":249}` on the semaglutide page. Read on August 9, 2026.

Between $2,988 and $3,030 for semaglutide on the monthly plan, and $3,564 to $3,614 for tirzepatide — the range exists because TMates bills every 30 days rather than every calendar month, which works out to about 12.2 charges a year instead of 12. Its subscription agreement puts it plainly: "I will be charged $--- for my first 30 day supply and $--- every 30 days thereafter until I cancel." Prepaying twelve months brings semaglutide to $1,900 and tirzepatide to $1,999, which is a genuine saving of roughly $1,100 and $1,600 against paying monthly — the largest prepay discount in this category, and the reason the headline is so far from the walk-away price.

Arithmetically it’s the best deal on the page; practically it’s a bet on tolerating the drug. Around a third of people who start a GLP-1 stop within the first few months, most often for gastrointestinal side effects, and TMates's refund ladder gives you nothing back once the prescription has been written and sent to the pharmacy. So $1,900 buys twelve months at $158 if you finish, and buys an expensive two months if you don’t. The three-month block at $650 splits the difference: $217 a month, a 13% saving, and a commitment short enough that you will know whether the drug suits you before renewing.

No, and unusually you can verify that rather than trust it. In TMates's own product data the price is attached to the plan, not to the dose — the dose selector is a separate field with no price attached anywhere on it. Semaglutide is $249 at 0.25 mg and $249 at 2.4 mg; tirzepatide is $297 across all six injectable strengths from 2.5 mg to 15 mg. For a drug you titrate upward over months, that turns a quoted price into a budget. It also means the $1,900 twelve-month block doesn’t quietly become $2,400 when you reach a maintenance dose, which is the trap in most annual GLP-1 pricing.

No. The checkout's order summary has three lines — subtotal, shipping marked FREE, and total — with no service fee, platform fee, membership or consultation charge, and the weight-loss page's promises are "NO HIDDEN FEES", "NO MONTHLY MEMBERSHIP" and "Prescription & telemed visits included". That matters more than it sounds: several competitors add a percentage "service fee" that appears for the first time on that same screen. What TMates does add is a fifteen-minute countdown timer at the top of the page, which is a sales device rather than a cost, and a note that it can’t deliver to a PO box.

It depends on one thing: whether a prescription has been written. TMates's Terms set out three tiers. Before the medical team reviews your history, a 100% refund. After review, if you don’t qualify for a plan, a 100% refund — and the checkout repeats this as "If I am medically disqualified, I will be refunded and my subscription will be canceled". Once you qualify and a prescription is transmitted to a pharmacy, no refund. The Terms add two things worth knowing: an unapproved refund request leaves any payment plan in force, and TMates reserves the right to use collections agencies against a chargeback. Canceling a live subscription is separate and free — portal, phone or email, at least two days before the next billing date.

Every state, yes — Washington, D.C. is the exception. TMates's marketing isn’t a reliable source here: the homepage says "all 50 states", the product FAQ says only "We ship to most states", and the About page claims "50+ States We Deliver", a number that can’t exist. The answer comes instead from the intake app itself, which asks "Where are you located?" from a list of exactly fifty, and from the shipping-address selector at checkout, which offers the same fifty. Neither includes the District of Columbia, so a D.C. address has nowhere to go in the signup flow.

That’s not a price for Wegovy. TMates lists brand-name Wegovy and Zepbound at $99 a month, and both are flagged "Clinical Service Only" — what $99 buys is the online evaluation, the prescription and dose management, with the prescription sent to your own pharmacy, where you then pay for the drug. TMates's own product data marks these `clinicalOnly: true` and the page says "Includes clinical evaluation & prescription management" rather than including medication. Whether it’s worth $99 a month depends entirely on what your pharmacy or manufacturer self-pay program charges for the drug itself, which is where the real money is. It’s disclosed, but the $99 sits under a large "Wegovy®" headline, and it’s the easiest number on this site to misread.

The pricing is the most transparent thing about TMates and the corporate claims are the least. "Our Doctors" names not one doctor; it asserts board certification and top-50 medical schools, then shows the marks of Harvard, Mayo Clinic, NIH and WebMD with no stated relationship. The About page claims ten-plus years of experience for a company whose Terms are dated August 2025, and describes TMates as "a manufacturer" on the same page whose footer says it’s not a 503A or 503B compounding facility. The patient count is 70,000, 100,000 or 40,000 depending on which page you’re reading, no pharmacy is named, and no street address is published. None of that changes what you will be charged — the prices reconcile across the plan data, the structured data and the checkout — but it’s the part of this site that hasn’t been checked by anyone.